PRIZM Clinical Trial of Zagociguat in Patients With MELAS by Madaline Spencer and Joe Haddad| Published on: Mar 17, 2026

PRIZM Clinical Trial of Zagociguat in Patients With MELAS by Madaline Spencer and Joe Haddad| Published on: Mar 17, 2026 Amel Karaa, MD, Genetics and General Metabolism, Director of the Mitochondrial Disease Program at Massachusetts General Hospital, discusses the PRIZM clinical trial of zagociguat in patients with MELAS. https://checkrare.com/prizm-clinical-trial-of-zagociguat-in-patients-with-melas/